Global Next-Generation Biologics Market 2016-2020

Published: Nov 2016
Pages: 124
SKU: IRTNTR10904

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version!

This market research study analyzes the leading players in the global next-generation biologics market such as Biogen, F. Hoffmann-La Roche, Novo Nordisk, Sanofi, and Takeda Pharmaceuticals. A competitive analysis of this market is also presented by therapies (next-generation regenerative medicine, next-generation antibodies, next-generation insulin products, next-generation recombinant coagulation factors) and by geography (the Americas, APAC, and EMEA).

Global next-generation biologics market outlook

According to the next generation biologics market analysis, the market is anticipated to witness staggering growth and will post a staggering CAGR of more than 14% during the forecast period. The increasing demand for antibody drug conjugates (ADCs) is one of the major factors driving this market’s growth. ADCs are highly effective cytotoxic drugs linked to a mAbs. These drugs have shown to be potent and efficient in treating diseases, including cancers and hematological malignancies. Therefore, in recent years, antibodies have become the preferred choice to treat respiratory, oncology, and inflammatory diseases.

The use of ADCs, including radioimmunotherapy and antibody-directed enzyme prodrug therapy, has increased significantly. The augmented use of these antibodies in drug development increases revenue generation in the global next-generation biologics market, thereby contributing to market growth.

Next-generation biologics market trends

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview
Top-vendor offerings

PART 03: Market research methodology

Research methodology
Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview
Five forces analysis

PART 06: Market segmentation by application

Global regenerative medicine market
Global next-generation antibodies market
Global next-generation insulin products market
Global next-generation recombinant coagulation factors market

PART 07: Geographical segmentation

Next-generation biologics market in Americas
Next-generation biologics market in EMEA
Next-generation biologics market in APAC

PART 08: Market drivers

Increase in demand for ADCs
Advanced technological innovations
Reimbursement support for next-generation biologics
Special regulatory drug designations for biologics

PART 09: Impact of drivers

PART 10: Market challenges

Complexities in manufacturing of biologics
Complicated regulatory framework
Difficulties in patient recruitment for conducting clinical trials, high cost, and failure rate in clinical trials
Critical ethical challenges in clinical trial design

PART 11: Impact of drivers and challenges

PART 12: Market trends